Critical review of efficacy of Pushyanug Churna in Raktapradara
Abstract
Aptopadesha is one of the Pramana accepted in Ayurveda. Many of the times physician may not be knowing the mode of action of certain Dravyas in clinical practice but they are used frequently in treating the patients and they also give very good results. Here the attempt is made to study the efficacy of Pushyanug Churna in Raktapradara (Abnormal menstrual bleeding), a common and serious etiological condition in females.
Downloads
References
Agnivesha, Charaksamhita, part II, 19th edition, Varanasi, Chaukhambha Bharati Academy, 1993, page no. 853- 854.
Prof. (Km.) Premvati Tewari, Ayurvediya Prasutitantra evam Striroga part II, 2nd edition, Varanasi, Chaukhambha orientalia, 2000, page no. 172-177, 181, 185,195.
Sri Govinda Dasa Sena Bhaishajyaratnavali edited and enlarged by Bhisagratna Sri Brahmasankara Misra Vidyotini hindi commentary, Analysis and Appendices by Kaviraja Sri Ambikadatta Sastri Editor Sri Rajesvaradattasastri, 2nd edition, Varanasi, Chaukhambha Prakashan, 2021, page no. 1032.
Prof. P. V. Sharma, Dravyaguna vijnana, Vol II (vegetable drugs), Varanasi, Chaukhambha Bharati Academy, page no. 627, 660, 651, 537, 627, 492, 749, 465, 139, 356, 456, 371, 616, 470, 363, 333, 134, 718, 516, 799, 472, 254, 196, 784, 352, 814, 44.
Copyright (c) 2024 Pratima Shikerkar, Gandhali Upadhye
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.